These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11891415)

  • 41. Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.
    Kuwano T; Bi X; Cipollari E; Yasuda T; Lagor WR; Szapary HJ; Tohyama J; Millar JS; Billheimer JT; Lyssenko NN; Rader DJ
    J Lipid Res; 2017 Apr; 58(4):731-741. PubMed ID: 28137768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice.
    Moerland M; Samyn H; van Gent T; Jauhiainen M; Metso J; van Haperen R; Grosveld F; van Tol A; de Crom R
    J Lipid Res; 2007 Dec; 48(12):2622-31. PubMed ID: 17761633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inducible expression of phospholipid transfer protein (PLTP) in transgenic mice: acute effects of PLTP on lipoprotein metabolism.
    Moerland M; Anghelescu N; Samyn H; van Haperen R; van Gent T; Strouboulis J; van Tol A; Grosveld F; de Crom R
    Transgenic Res; 2007 Aug; 16(4):503-13. PubMed ID: 17437182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles.
    Dullaart RPF; Gruppen EG; Dallinga-Thie GM
    Clin Biochem; 2016 Apr; 49(6):508-510. PubMed ID: 26656640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phospholipid transfer protein in lipid metabolism.
    Huuskonen J; Ehnholm C
    Curr Opin Lipidol; 2000 Jun; 11(3):285-9. PubMed ID: 10882344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis.
    van Haperen R; Samyn H; Moerland M; van Gent T; Peeters M; Grosveld F; van Tol A; de Crom R
    PLoS One; 2008 May; 3(5):e2255. PubMed ID: 18509527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S; van Tol A; Sluiter W; Dullaart R
    Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies.
    Albers JJ; Wolfbauer G; Cheung MC; Day JR; Ching AF; Lok S; Tu AY
    Biochim Biophys Acta; 1995 Aug; 1258(1):27-34. PubMed ID: 7654777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adipocyte phospholipid transfer protein and lipoprotein metabolism.
    Jiang H; Yazdanyar A; Lou B; Chen Y; Zhao X; Li R; Hoang Bui H; Kuo MS; Navab M; Qin S; Li Z; Jin W; Jiang XC
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):316-22. PubMed ID: 25477345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.
    Borggreve SE; De Vries R; Dullaart RP
    Eur J Clin Invest; 2003 Dec; 33(12):1051-69. PubMed ID: 14636288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein.
    Dallinga-Thie GM; van Tol A; Dullaart RP;
    Biochim Biophys Acta; 2009 Aug; 1791(8):714-8. PubMed ID: 19303940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity.
    Yan D; Navab M; Bruce C; Fogelman AM; Jiang XC
    J Lipid Res; 2004 Oct; 45(10):1852-8. PubMed ID: 15258196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phospholipid transfer protein deficiency decreases the content of S1P in HDL via the loss of its transfer capability.
    Yu Y; Guo S; Feng Y; Feng L; Cui Y; Song G; Luo T; Zhang K; Wang Y; Jiang XC; Qin S
    Lipids; 2014 Feb; 49(2):183-90. PubMed ID: 24158769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Introduction of the human PLTP transgene suppresses the atherogenic diet-induced increase in plasma phospholipid transfer activity in C57BL/6 mice.
    Tu AY; Paigen B; Wolfbauer G; Cheung MC; Kennedy H; Chen H; Albers JJ
    Int J Clin Lab Res; 1999; 29(1):14-21. PubMed ID: 10356658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
    Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
    Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated expression of PLTP is atherogenic in apolipoprotein E deficient mice.
    van Haperen R; van Gent T; van Tol A; de Crom R
    Atherosclerosis; 2013 Mar; 227(1):37-42. PubMed ID: 23313246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells.
    Desrumaux CM; Mak PA; Boisvert WA; Masson D; Stupack D; Jauhiainen M; Ehnholm C; Curtiss LK
    J Lipid Res; 2003 Aug; 44(8):1453-61. PubMed ID: 12730304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.
    O'Brien KD; Vuletic S; McDonald TO; Wolfbauer G; Lewis K; Tu AY; Marcovina S; Wight TN; Chait A; Albers JJ
    Circulation; 2003 Jul; 108(3):270-4. PubMed ID: 12835223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes.
    Colhoun HM; Taskinen MR; Otvos JD; Van Den Berg P; O'Connor J; Van Tol A
    Diabetes; 2002 Nov; 51(11):3300-5. PubMed ID: 12401722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.